Dec 17, 2018

Biotech startup Kineta inks cancer deal with Pfizer worth up to $505M

Posted by in category: biotech/medical

The Seattle-based biotech company will use the funding in its efforts to kill cancerous tumors using the same immune system response pathway that fights the flu.

Read more

Comments are closed.